My Account

Username :

Password :


Create New Account
Forgot Password?
     

Keyword Search


     

Speakers


Browse all CYTO Speakers

     

Shopping Cart

You have (0) items
in your cart.



     

Contact Us


EMAIL US

     

Return to Digital Conference Providers Inc. Events Library Menu





PURCHASE THE SCIENTIIFIIC SESSION PACKAGE FOR A TOTAL OF 18.25 CREDITS!


Scientific Session Podcast Package for Attendee - Only
$149.25
Scientific Session Podcast Package for Non-Attendee - $199.00


Download the Scientific Session Podcast consisting of all available session video (MP4 Format). These can be downloaded to your computer and transferred to compatible mobile devices. With each download subscription you will enjoy unlimited access to your purchased files. You may download as many times as desired for one set price. Your account will not expire, so be sure to keep your log in information for future access and purchases.

Download Video (MP4 Format): Individual MP4 files are synchronized video files that combine all recorded audio with presentation slides. MP4s are playable on a computer or MP4 compatible device.

Visit American Society of Cytopathology Meeting Home:
http://cytopathologymeeting.org/2013/
Purchase the Same Content on DVD-ROM Delivered by Mail: https://www.dcporder.com/cyto/


CME/CMLE credit available for each session (SAM credits on select sessions). Credit good for 3 years.

Total Credits Available: N/A at this time. Please check back shortly.

The PDF files to claim credits for each sessions will be available after purchase

$199.00



Showing sessions 1 - 10 of (13) TOTAL sessions
(PREV 10)  1 2    (NEXT 10)


Event : CYTO104


Session : CYTO1301
HT1: HPV Testing in Cervical Cancer Screening: Why? How? Are There Pitfalls?
Hot Topic (2.5 CME/CMLE)
Conference : All Scientific Sessions (2013)
Speaker(s) : R. Marshall Austin, MD, PhD , George G. Birdsong, MD , Lisa Flowers, MD , Jane S. Gibson, PhD, FACMG , Mark H. Stoler, MD , David C. Wilbur, MD
  • Description: Human papillomavirus (HPV) testing has played an important role in cervical cancer screening for more than a decade, first as a reflex test for women with ASC-US Pap tests, and more recently as a co-test with the Pap test, and even as the primary test for cervical cancer screening in some clinical trials. This year's Hot Topic session will provide an overview of multiple aspects of HPV testing including the basic science and epidemiology, FDA approved methodologies, laboratory developed tests and associated regulatory issues, and possible pitfalls.
  • Learning Objectives: 1.) Discuss the basics understanding the basic science and epidemiology of HPV as it relates to cervical cancer 2.) Discuss the methodologies of the various FDA approved assays for HPV 3.) Discuss possible pitfalls of HPV testing as a method of cervical cancer screening 4.) Discuss the regulatory issues surrounding laboratory developed assays for HPV
  • Click the PDF icon to claim your CME/CMLE/SAM credits


Session : CYTO1302
SS01: State of the Society
Special Event - NO CREDITS AVAILABLE FOR THIS SESSION
Conference : All Scientific Sessions (2013)
Speaker(s) : Jill L. Caudill, MEd, SCT(ASCP)CM , William N. Crabtree, PhD, SCT(ASCP) , Ritu Nayar, MD, MIAC , Andrew A. Renshaw, MD


Session : CYTO1305
SS1: 25 Years Ago, CLIA'88 Happened
History of the Society (0.5 CME/CMLE)
Conference : All Scientific Sessions (2013)
Speaker(s) : Diane D. Davey, MD
  • Click the PDF icon to claim your CME/CMLE/SAM credits


Session : CYTO1306
SS2: Papanicolaou Address
(0.5 CME/CMLE)
Conference : All Scientific Sessions (2013)
Speaker(s) : George G. Birdsong, MD
  • Click the PDF icon to claim your CME/CMLE/SAM credits


Session : CYTO1308
SS3: Biomedical Imaging Using Optical Coherence Tomography (OCT)
Leopold Koss Lectureship (1.0 CME/CMLE)
Conference : All Scientific Sessions (2013)
Speaker(s) : James G. Fujimoto, PhD
  • Description: Optical coherence tomography (OCT) is an emerging imaging modality which uses echoes of light to generate micron resolution, cross-sectional and three dimensional images of tissue architectural morphology. OCT imaging depth is limited to ~2 to 3 mm in most tissues, however imaging can be performed using catheters and endoscopes. OCT enables ""optical biopsy."" visualizing tissue microstructure in situ and in real time. 3D functional imaging of Doppler blood flow and vascular contrast is also possible. OCT is now a standard diagnostic in ophthalmology, with over 20 million procedures yearly. It is also being developed in applications ranging from intravascular to endoscopic imaging. This presentation reviews OCT technology and its applications.
  • Learning Objectives: 1.) Understand the principles of operation of optical coherence tomography (OCT) 2.) Describe major clinical applications of OCT 3.) Understand an example of new imaging technology development and translation
  • Click the PDF icon to claim your CME/CMLE/SAM credits


Session : CYTO1309
SS4: CLIA '88 and Cytopathology: How Was Our Practice Affected?
Current Issues in Cytology (1.5 CME/CMLE/SAM)
Conference : All Scientific Sessions (2013)
Speaker(s) : R. Marshall Austin, MD, PhD , George G. Birdsong, MD , Diane D. Davey, MD , M. Sue Zaleski, MA, SCT(ASCP)
  • Description: Several media reports in 1987-88, including the Wall Street Journal, brought attention to possible deficiencies in laboratory quality. Cut-rate "Pap mills" brought scrutiny to cytology laboratories, and Congress subsequently passed the Clinical Laboratory Improvement Amendments of 1988 (CLIA '88). In this 25th anniversary panel, we will discuss the major regulatory changes that resulted including proficiency testing, workload limits, and laboratory inspection and accreditation processes. The negative publicity and the retrospective rescreening requirements lead to a major spike in litigation related to "false negative" Pap tests and ultimately encouraged the development of new cytology technologies.
  • Learning Objectives: 1.) Describe the changes in laboratory inspection and accreditation processes following CLIA '88 2.) Discuss the litigation consequences that resulted from publicity related to CLIA '88 and the retrospective review requirements 3.) Discuss the history and impact of proficiency testing, workload limits and other major CLIA '88 laboratory regulations 4.) Postulate how the changes brought by CLIA '88 and publicity related to adverse patient outcomes influenced the development of new cytology technologies
  • Click the PDF icon to claim your CME/CMLE/SAM credits


Session : CYTO1311
SS5: CLIA '88: First Person Account
Guest Lecture (0.75 CME/CMLE)
Conference : All Scientific Sessions (2013)
Speaker(s) : Walt Bogdanich
  • Description: Three-time Pulitzer Prize recipient Walt Bogdanich will give us a glimpse into his writing the three 1987 Wall Street Journal articles that led to CLIA '88. This year marks the 25th anniversary of President Ronald Reagan's signing it into law on October 31, 1988. Living history at its best!
  • Learning Objectives: 1.) Provide an investigative reporter's perspective on his role in CLIA '88 2.) Encourage medical professionals to influence relevant regulatory issues 3.) Teach: ""The more things change, the more they remain the same""
  • AUDIO ONLY
  • Click the PDF icon to claim your CME/CMLE/SAM credits


Session : CYTO1315
SS6: Platform Presentations 1 - 6
(1.5 CME/CMLE)
Conference : All Scientific Sessions (2013)
Speaker(s) :
  • Click the PDF icon to claim your CME/CMLE/SAM credits


Session : CYTO1316
SS7: Platform Presentations 7 - 14
(2.0 CME/CMLE)
Conference : All Scientific Sessions (2013)
Speaker(s) :
  • Click the PDF icon to claim your CME/CMLE/SAM credits


Session : CYTO1319
SS8: Guiding the Cells - The Cytologist's Role in Procurement, Diagnosis, and Molecular Studies of Lung Carcinomas and Mesotheliomas
State of the Art Symposium (2.5 CME/CMLE/SAM)
Conference : All Scientific Sessions (2013)
Speaker(s) : Kristen A. Atkins, MD , Sanja Dacic, MD, PhD , Benjamin R. Kipp, PhD , Maureen F. Zakowski, MD
  • Description: This last year brought many guidelines in lung cancer nomenclature and recommendations for molecular testing. Cytologists are at the forefront of biopsy diagnosis and triaging specimens for potential ancillary testing. Laboratories are faced with weighing the pros and cons of sending the specimens out for testing or performing the tests within their own laboratory. Each option brings questions to the appropriate way to handle the material and validate the test. This presentation will review all of these topics with speakers who face these challenges daily and are involved in the groups making the recommendations.
  • Learning Objectives: 1.) Know the current guidelines for the utilization of EGFR and ALK testing in lung cancers 2.) Have a working knowledge of how to validate new molecular tests in a lab 3.) Be familiar with the proposed nomenclature for lung malignancies and how this applies to cytologic samples 4.) Utilize ancillary tests in the diagnosis of mesothelioma
  • Click the PDF icon to claim your CME/CMLE/SAM credits



     


Showing sessions 1 - 10 of (13) TOTAL sessions
(PREV 10)  1 2    (NEXT 10)


All Libraries

Contact Us : customersupport@dcproviders.com
Digital Conference Providers, Inc. - 100 S. Cass Ave. Ste 200 - Westmont, IL 60559
Phone (781) 832-0907

(c) [2016] Digital Conference Providers, Inc. All rights reserved. No part of this recorded content may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopy, recording, or otherwise, without the prior written permission of Digital Conference Providers, Inc. All sales are final and are intended for individual use.